{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:04:16Z","timestamp":1762625056774,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ymgme.2023.107634","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:05:20Z","timestamp":1687813520000},"page":"107634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigation of bone mineral density and the changes by enzyme replacement therapy in patients with Fabry disease"],"prefix":"10.1016","volume":"139","author":[{"given":"Yuma","family":"Nose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107634_bb0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","article-title":"Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study","volume":"58","author":"Inoue","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107634_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41436-018-0010-z","article-title":"Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients","volume":"21","author":"Hsu","year":"2019","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2023.107634_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166484","article-title":"Skin Globotriaosylceramide 3 load is increased in men with advanced Fabry disease","volume":"11","author":"\u00dc\u00e7eyler","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2023.107634_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ndt\/gfaa298","article-title":"Urinary mulberry bodies as a potential biomarker for early diagnosis and efficacy assessment of enzyme replacement therapy in Fabry nephropathy","volume":"37","author":"Yonishi","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2023.107634_bb0025","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2023.107634_bb0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10157-017-1525-3","article-title":"Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy","volume":"22","author":"Sakuraba","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ymgme.2023.107634_bb0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry\u2019s disease with the pharmacologic chaperone Migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107634_bb0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-021-21371-5","article-title":"Lentivirus-mediated gene therapy for Fabry disease","volume":"12","author":"Khan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2023.107634_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0004.2005.00457.x","article-title":"Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease","volume":"68","author":"Germain","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2023.107634_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/GIM.0b013e31815cb197","article-title":"Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density","volume":"9","author":"Mersebach","year":"2007","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2023.107634_bb0055","first-page":"29","article-title":"Antiepileptic medications increase osteoporosis risk in male fabry patients: bone mineral density in an Australian cohort","volume":"17","author":"Talbot","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2023.107634_bb0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","article-title":"Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns","volume":"55","author":"Lee","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107634_bb0065","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ymgme.2023.107634_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10157-014-1042-6","article-title":"Reference glomerular filtration rate levels in Japanese children: using the creatinine and cystatin C based estimated glomerular filtration rate","volume":"19","author":"Uemura","year":"2015","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ymgme.2023.107634_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric official positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.ymgme.2023.107634_bb0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00774-007-0839-8","article-title":"Which element of physical activity is more important for determining bone growth in Japanese children and adolescents: the degree of impact, the period, the frequency, or the daily duration of physical activity?","volume":"26","author":"Tamaki","year":"2008","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ymgme.2023.107634_bb0085","first-page":"85","article-title":"A longitudinal study on bone mineral density at lumbar spine and total hip and its determinants in Japanese adolescents. Focus on sports activity at jumior high school and high school","volume":"26","author":"Naka","year":"2005","journal-title":"Descente Sports Sci."},{"key":"10.1016\/j.ymgme.2023.107634_bb0090","series-title":"Annual Study Reports on Milk Nutrition sponsored by Japan Dairy Association","first-page":"76","article-title":"Completion of a 4-year follow-up study to evaluate the effect of milk and dairy product intake on midshaft bone development and enrichment in first-year middle school boys and girls by estimated volumetric bone mineral density","author":"Iki","year":"2004"},{"key":"10.1016\/j.ymgme.2023.107634_bb0095","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00198-022-06420-z","article-title":"Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease","volume":"33","author":"Bruell","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2023.107634_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","article-title":"Bone and calcium metabolism and antiepileptic drugs","volume":"112","author":"Verrotti","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymgme.2023.107634_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yebeh.2011.05.001","article-title":"Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs","volume":"21","author":"Pack","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ymgme.2023.107634_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1096\/fba.2019-00080","article-title":"Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg(CAG-A4GALT) mouse model of Fabry disease","volume":"2","author":"Maruyama","year":"2020","journal-title":"FASEB Bioadv."},{"key":"10.1016\/j.ymgme.2023.107634_bb0115","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.10391","article-title":"Avascular necrosis of the femoral head in a patient with Fabry\u2019s disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry","volume":"46","author":"Horiuchi","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymgme.2023.107634_bb0120","first-page":"807","article-title":"Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients","volume":"32","author":"Skrunes","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2023.107634_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"International collaborative Fabry disease study group. Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107634_bb0130","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2023.107634_bb0135","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:15Z","timestamp":1761090855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1096719223002640"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107634","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of bone mineral density and the changes by enzyme replacement therapy in patients with Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107634"}}